According to the new market research report “Clinical Microbiology Market by Application (Food, Pharma, Manufacturing, Chemical, Environment), Disease (Respiratory, Std, Uti), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnostic Lab, Academia) – Global Forecast to 2025″, size is estimated to be USD 3.9 billion in 2020 and projected to reach USD 5.3 billion by 2025, at a CAGR of 6.5%.
The increasing prevalence of infectious diseases and growing outbreak of
epidemics (such as COVID-19), technological advancements, and increased
funding and public-private investments are the key factors driving the
growth of the orthopedic braces and supports the industry.
Browse and in-depth TOC on “Clinical Microbiology Market”
177 – Tables
37 – Figures
228 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367
Growth in the nuclear medicine market can primarily be attributed to
factors such as the increasing incidence and prevalence of cancer and
cardiac ailments and initiatives to lessen the demand-supply gap of
Mo-99. However, the short half-life of radiopharmaceuticals reduces
their potential adoption, while hospital budget cuts and high equipment
prices are expected to limit market growth to a certain extent.
The companies have a large market spread across various countries in
North America, Europe, Asia Pacific, and the Rest of the World.
Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious
disease caused by severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2). Largely unknown before the outbreak began in Wuhan, China,
in December 2019, COVID-19 has moved from a regional crisis to a global
pandemic in just a few weeks. The World Health Organization (WHO)
declared COVID-19 as a pandemic on March 11, 2020. The COVID-19 pandemic
has led to major changes in the clinical operations of radiology
departments worldwide. In parallel with clinical preparedness
activities, academic medical centers and universities were rushed to
shut down scientific research activities to maximize social distancing
and minimize the spread of infection to research staff and others with
whom they might have contact.
Therapeutic segment is expected to grow at the highest CAGR
On
the basis of type, the nuclear medicine market is segmented into
diagnostic and therapeutic. The diagnostic segment accounted for a
larger share of the market 2020. The large share of this segment can be
attributed to the non-invasiveness, increasing prevalence of
cardiovascular diseases and early diagnosis.
Thyroid applications segment is expected to register the highest growth during the forecast period
Based on application, the nuclear medicine market is segmented into
SPECT, PET, and therapeutic applications. The SPECT applications is
further segmented into cardiology, bone scans, thyroid applications,
pulmonary scans, and other SPECT applications. The thyroid applications
segment is projected to register the highest growth rate in the forecast
period. The high growth of this segment can be attributed to the
increasing incidence and prevalence of thyroid disorders
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219135367
North America to Witness Significant Growth from 2021 To 2026
In 2020, North America accounted for the largest share of the nuclear
medicine market. A large share of North America can be attributed to the
large share can be attributed to the development of novel technologies
for radioisotope production, government funding, and company initiatives
in the region.
Some of the prominent players operating in the
Radiopharmaceuticals Market include Cardinal Health (US), GE Healthcare
(US), Curium (France), Lantheus Medical Imaging (US), Bayer AG
(Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products
(Turkey), Nordion (Canada), Advanced Accelerator Applications (France),
and NTP Radioisotopes (South Africa)
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/microbiology-testing.asp
